SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Oct-24 7:14 PM View: | Spatializer Audio Laborator... (AMRH) | 09-Oct-24 | Grant | 47,733 | -- | -- | 4773% 1.0K to 48.73K | |
19-Sep-23 5:34 PM View: | Spatializer Audio Laborator... (AMRH) | 15-Sep-23 | Purchase | 1,000 | $2.14 | $2,140.00 | 100% 0 to 1.0K | |
23-Nov-21 8:25 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Nov-21 | Payment of Exercise | 3,779 | $8.36 | $31,592.40 | (< 1%) 433.56K to 429.78K | (< 1%) |
24-Aug-21 6:57 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-21 | Payment of Exercise | 3,779 | $14.05 | $53,094.90 | (< 1%) 437.34K to 433.56K | (< 1%) |
24-May-21 6:12 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-21 | Payment of Exercise | 3,779 | $17.80 | $67,266.20 | (< 1%) 441.12K to 437.34K | 2% |
23-Feb-21 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-21 | Payment of Exercise | 26,961 | $18.79 | $506,597.00 | (6%) 466.68K to 439.72K | 4% |
10-Feb-21 5:45 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Feb-21 | Grant | 65,000 | -- | -- | 16% 401.68K to 466.68K | |
24-Nov-20 6:17 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-20 | Payment of Exercise | 4,214 | $17.21 | $72,522.90 | (1%) 405.89K to 401.68K | (9%) |
24-Aug-20 6:27 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-20 | Payment of Exercise | 4,214 | $18.22 | $76,779.10 | (1%) 410.11K to 405.89K | (3%) |
22-May-20 6:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-20 | Payment of Exercise | 4,214 | $26.67 | $112,387.00 | (1%) 414.32K to 410.11K | 30% |
24-Feb-20 7:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-20 | Payment of Exercise | 24,392 | $25.90 | $631,753.00 | (6%) 437.31K to 412.92K | 28% |
05-Feb-20 7:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-Feb-20 | Grant | 119,000 | -- | -- | 37% 318.31K to 437.31K | |
22-Nov-19 6:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-19 | Payment of Exercise | 2,447 | $17.60 | $43,067.20 | (< 1%) 320.76K to 318.31K | (7%) |
22-Aug-19 6:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-19 | Payment of Exercise | 2,335 | $21.51 | $50,225.90 | (< 1%) 323.09K to 320.76K | 13% |
22-May-19 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-19 | Payment of Exercise | 1,604 | $19.84 | $31,823.40 | (< 1%) 324.7K to 323.09K | 5% |
22-Feb-19 6:16 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-19 | Payment of Exercise | 4,919 | $27.00 | $132,813.00 | (1%) 328.59K to 323.67K | 31% |
07-Feb-19 5:46 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-19 | Grant | 112,250 | -- | -- | 52% 216.34K to 328.59K | |
21-Nov-18 5:45 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-18 | Payment of Exercise | 5,735 | $24.79 | $142,171.00 | (3%) 222.07K to 216.34K | |
22-Aug-18 7:33 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-18 | Payment of Exercise | 5,735 | $26.95 | $154,558.00 | (3%) 227.81K to 222.07K | |
22-May-18 7:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-18 | Payment of Exercise | 18,424 | $24.31 | $447,887.00 | (7%) 246.23K to 227.81K | |
16-May-18 7:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-May-18 | Grant | 33,750 | -- | -- | 16% 212.48K to 246.23K | |
22-Feb-18 5:40 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-18 | Payment of Exercise | 4,741 | $29.09 | $137,916.00 | (2%) 216.36K to 211.62K | |
14-Feb-18 6:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 12-Feb-18 | Grant | 9,000 | -- | -- | 4% 207.36K to 216.36K | |
22-Nov-17 4:38 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-17 | Payment of Exercise | 5,820 | $28.58 | $166,336.00 | (3%) 213.18K to 207.36K | |
23-Aug-17 5:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 21-Aug-17 | Purchase | 4,000 | $26.34 | $105,359.00 | 2% 209.18K to 213.18K | |
22-Aug-17 6:29 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-17 | Payment of Exercise | 5,820 | $27.40 | $159,468.00 | (3%) 215.0K to 209.18K | |
23-May-17 8:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-17 | Payment of Exercise | 5,820 | $36.83 | $214,351.00 | (3%) 220.82K to 215.0K | |
22-Feb-17 7:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-17 | Payment of Exercise | 8,762 | $33.78 | $295,980.00 | (4%) 227.88K to 219.12K | |
08-Feb-17 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Feb-17 | Grant | 9,000 | -- | -- | 4% 218.88K to 227.88K | |
17-Mar-16 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Mar-16 | Grant | 90,000 | -- | -- | 71% 127.18K to 217.18K | |
23-Feb-16 7:55 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-16 | Payment of Exercise | 10,830 | $15.65 | $169,490.00 | (8%) 138.01K to 127.18K | |
09-Feb-15 7:56 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-15 | Grant | 130,000 | -- | -- | 2275% 5.71K to 135.71K | |
27-Jan-14 7:18 PM View: | Theravance Inc. (INVA) | 23-Jan-14 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |